These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 27435502)

  • 1. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
    Bertoli G; Cava C; Castiglioni I
    Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.
    Asghari F; Haghnavaz N; Baradaran B; Hemmatzadeh M; Kazemi T
    Biomed Pharmacother; 2016 Jul; 81():305-317. PubMed ID: 27261608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
    Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
    Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dual Regulatory Role of MiR-181a in Breast Cancer.
    Yang C; Tabatabaei SN; Ruan X; Hardy P
    Cell Physiol Biochem; 2017; 44(3):843-856. PubMed ID: 29176320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
    Goh JN; Loo SY; Datta A; Siveen KS; Yap WN; Cai W; Shin EM; Wang C; Kim JE; Chan M; Dharmarajan AM; Lee AS; Lobie PE; Yap CT; Kumar AP
    Biol Rev Camb Philos Soc; 2016 May; 91(2):409-28. PubMed ID: 25631495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
    Petrović N; Nakashidze I; Nedeljković M
    J Mammary Gland Biol Neoplasia; 2021 Jun; 26(2):157-178. PubMed ID: 33479880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
    Greene SB; Herschkowitz JI; Rosen JM
    Curr Drug Targets; 2010 Sep; 11(9):1059-73. PubMed ID: 20545613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
    Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
    Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
    van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
    Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of miRNA in the diagnosis and treatment of breast cancer.
    Castañeda CA; Agullo-Ortuño MT; Fresno Vara JA; Cortes-Funes H; Gomez HL; Ciruelos E
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1265-75. PubMed ID: 21916580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.
    Hannafon BN; Ding WQ
    Am J Pathol; 2019 May; 189(5):966-974. PubMed ID: 30273605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.